2024 |
Corrigendum to “SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease” [J Hepatol 80 (2024) 10-19, (S0168827823051474), (10.1016/j.jhep.2023.09.020)] |
Nota o commento |
Vai |
2024 |
The PD-1/PD-L1 Axis in the Biology of MASLD |
Review essay (rassegna critica) |
Vai |
2024 |
SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease |
Articolo in rivista |
Vai |
2023 |
Metabolic memory in diabetic foot syndrome (DFS): MICRO-RNAS, single nucleotide polymorphisms (SNPs) frequency and their relationship with indices of endothelial function and adipo-inflammatory dysfunction |
Articolo in rivista |
Vai |
2023 |
Red and golden tomato administration improves fat diet-induced hepatic steatosis in rats by modulating HNF4α, Lepr, and GK expression |
Articolo in rivista |
Vai |
2023 |
Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease |
Articolo in rivista |
Vai |
2023 |
MAFLD: a multisystem disease |
Recensione in rivista |
Vai |
2023 |
Curcumin and Andrographolide Co-Administration Safely Prevent Steatosis Induction and ROS Production in HepG2 Cell Line |
Articolo in rivista |
Vai |
2023 |
Inflammation and autonomic balance in cirrhosis: Association between sympathetic nervous system and osteopontin, interleukin-22, interleukin-6 and interleukin-1Ra concentrations according to portal hypertension and disease severity |
Articolo in rivista |
Vai |
2022 |
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease |
Articolo in rivista |
Vai |
2022 |
Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development |
Articolo in rivista |
Vai |
2022 |
A cholestatic pattern predicts major liver-related outcomes in patients with non-alcoholic fatty liver disease |
Articolo in rivista |
Vai |
2021 |
Coffee Restores Expression of lncRNAs Involved in Steatosis and Fibrosis in a Mouse Model of NAFLD |
Articolo in rivista |
Vai |
2021 |
Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease |
Articolo in rivista |
Vai |
2021 |
PNPLA3 and TLL-1 Polymorphisms as Potential Predictors of Disease Severity in Patients With COVID-19 |
Articolo in rivista |
Vai |
2021 |
Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy |
Articolo in rivista |
Vai |
2021 |
NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver disease |
Articolo in rivista |
Vai |
2020 |
PNPLA3 rs738409 C>G Variant Predicts Fibrosis Progression by Noninvasive Tools in Nonalcoholic Fatty Liver Disease |
Articolo in rivista |
Vai |
2020 |
Hepatitis C virus eradication by direct antiviral agents abates oxidative stress in patients with advanced liver fibrosis |
Articolo in rivista |
Vai |
2020 |
SARS-CoV-2 Viral Load, IFNλ Polymorphisms and the Course of COVID-19: An Observational Study |
Articolo in rivista |
Vai |
2020 |
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease |
Articolo in rivista |
Vai |
2019 |
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity |
Articolo in rivista |
Vai |
2019 |
EPIGENETIC PROFILING AND THERAPEUTICS IN LIVER DISEASE |
Abstract in atti di convegno pubblicato in rivista |
Vai |
2019 |
NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients |
Articolo in rivista |
Vai |
2019 |
Role of myeloid-epithelial-reproductive tyrosine kinase and macrophage polarization in the progression of atherosclerotic lesions associated with nonalcoholic fatty liver disease |
Articolo in rivista |
Vai |
2018 |
Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis |
Articolo in rivista |
Vai |
2018 |
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver |
Articolo in rivista |
Vai |
2018 |
Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population |
Articolo in rivista |
Vai |
2017 |
Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease |
Articolo in rivista |
Vai |
2017 |
Fibronectin type III domain-containing protein 5 rs3480 A>G polymorphism, irisin, and liver fibrosis in patients with Nonalcoholic fatty liver disease |
Articolo in rivista |
Vai |
2017 |
Effects of Pimozide Derivatives on pSTAT5 in K562 Cells |
Articolo in rivista |
Vai |
2016 |
Novel iodoacetamido benzoheterocyclic derivatives with potent antileukemic activity are inhibitors of STAT5 phosphorylation |
Articolo in rivista |
Vai |
2016 |
Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension |
Articolo in rivista |
Vai |
2016 |
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent |
Articolo in rivista |
Vai |
2016 |
TM6SF2 rs58542926 is not associated with steatosis and fibrosis in largecohort of patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Vai |
2015 |
The UCP2 -866 G>A promoter region polymorphism is associated with nonalcoholic steatohepatitis |
Articolo in rivista |
Vai |
2015 |
MERTK rs4374383 polymorphism affects the severity of fibrosis in nonalcoholic fatty liver disease |
Articolo in rivista |
Vai |
2015 |
Statin use and non-alcoholic steatohepatitis in at risk individuals |
Articolo in rivista |
Vai |
2015 |
Transmembrane 6 Superfamily Member 2 Gene Variant Disentangles Nonalcoholic Steatohepatitis From Cardiovascular Disease |
Articolo in rivista |
Vai |
2015 |
PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C |
Articolo in rivista |
Vai |
2014 |
Inhibition of activated STAT5 in Bcr/Abl expressing leukemia cells
with new pimozide derivatives |
Articolo in rivista |
Vai |
2014 |
The risk of hepatocellular carcinoma in HBV cirrhosis is affected by polymorphisms of the MERTK gene |
Abstract in rivista |
Vai |
2014 |
Novel antiproliferative chimeric compounds with marked histone deacetylase inhibitory activity |
Articolo in rivista |
Vai |
2014 |
Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease |
Articolo in rivista |
Vai |
2013 |
A natural-like synthetic small molecule impairs bcr-abl signaling cascades and induces megakaryocyte differentiation in erythroleukemia cells |
Articolo in rivista |
Vai |
2013 |
The new iodoacetamidobenzofuran derivative TR120 decreases STAT5 expression and induces antitumor effects in imatinib-sensitive and imatinib-resistant BCR-ABL-expressing leukemia cells. |
Articolo in rivista |
Vai |
2013 |
In vivo liver expression of TLR2, TLR3 and TLR7 in chronic hepatitis C |
Articolo in rivista |
Vai |
2013 |
Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease |
Articolo in rivista |
Vai |
2013 |
PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease |
Articolo in rivista |
Vai |
2013 |
Role of IL-28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg-Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices. |
Articolo in rivista |
Vai |
2013 |
Association of vitamin D serum levels and its common genetic determinants with severity of liver fibrosis in genotype 1 chronic hepatitis C patients |
Proceedings |
Vai |
2013 |
Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients |
Articolo in rivista |
Vai |
2012 |
Liver follicular helper T-cells predict the achievement of virological response following interferon-based treatment in HCV-infected patients. |
Articolo in rivista |
Vai |
2012 |
Risk of disease decompensation and HCC in patients with HCV cirrhosis non responders to PEG IFN plus RBV |
Abstract in rivista |
Vai |
2012 |
IL28B and PNPLA3 Polymorphisms Affect Histological Liver Damage in Patients with Non-alcoholic Fatty Liver Disease. |
Articolo in rivista |
Vai |
2011 |
Synthesis, antiproliferative activity, and mechanism of action of a series of 2-{[2E]-3-phenylprop-2-enoylamino}benzamides |
Articolo in rivista |
Vai |
2011 |
3-Aryl-2-[1H-benzotriazol-1-yl]acrylonitriles: a novel class of potent tubulin inhibitors |
Articolo in rivista |
Vai |
2011 |
High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis |
Articolo in rivista |
Vai |
2011 |
Genetic predisposition to thrombophilia in inflammatory bowel disease |
Articolo in rivista |
Vai |
2011 |
Synthesis of novel antimitotic agents based on 2-amino-3-aroyl-5-(hetero)arylethynyl thiophene derivatives. |
Articolo in rivista |
Vai |
2011 |
PEG-INTERFERON PLUS RIBAVIRIN IN HCV CIRRHOSIS WITH PORTAL HYPERTENSION: ROLE OF VIRAL AND HOST FACTORS IN HCV CLEARANCE |
Abstract in rivista |
Vai |
2011 |
Liver follicular helper T-cells in chronic hepatitis C |
Abstract in rivista |
Vai |
2011 |
Synthesis of substituted 3-amino-N-phenyl-1H-indazole-1-carboxamides endowed with antiproliferative activity |
Articolo in rivista |
Vai |
2010 |
Substituted 2-(3',4',5'-trimethoxybenzoyl)-benzo[b]thiophene derivatives as potent tubulin polymerization inhibitors |
Articolo in rivista |
Vai |
2010 |
SYNTHESIS AND ANTIPROLIFERATIVE ACTIVITY OF 3-AMINO-N-PHENYL-1H-INDAZOLE-1-CARBOXAMIDES |
Proceedings |
Vai |
2009 |
Synthesis and antiproliferative activity of 3-amino-N-phenyl-1H-indazole-1-carboxamides |
Articolo in rivista |
Vai |
2009 |
Design, synthesis and structure-activity relationship of 2-(3',4',5'-trimethoxybenzoyl)-benzo[b]furan derivatives as a novel class of inhibitors of tubulin polymerization. |
Articolo in rivista |
Vai |
2009 |
Identification of biphenyl-based hybrid molecules able to decrease the intracellular level of Bcl-2 protein in Bcl-2 overexpressing leukemia cells. |
Articolo in rivista |
Vai |
2008 |
Novel Terphenyls and 3,5-Diaryl Isoxazole Derivatives Endowed with Growth Supporting and Antiapoptotic Properties |
Articolo in rivista |
Vai |
2008 |
Synthesis and biological evaluation of 2-(3',4',5'-trimethoxybenzoyl)-3-N,N-dimethylamino benzo[b]furan derivatives as inhibitors of tubulin polymerization |
Articolo in rivista |
Vai |
2008 |
Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-6-substituted-4,5,6,7-tetrahydrothieno[2,3-c]pyridine derivatives as antimitotic agents and inhibitors of tubulin polymerization |
Articolo in rivista |
Vai |
2008 |
Galangin increases the cytotoxic activity of imatinib mesylate in imatinib-sensitive and imatinib-resistant Bcr-Abl expressing leukemia cells |
Articolo in rivista |
Vai |
2008 |
Antiproliferative Agents That Interfere with the Cell Cycle at the G(1)-->S Transition: Further Development and Characterization of a Small Library of Stilbene-Derived Compounds |
Articolo in rivista |
Vai |
2007 |
Effetti antileucemici di due stilbeni identificati in uve provenienti da vigneti affetti da peronospora e Botrytis cinerea |
Articolo in rivista |
Vai |